title: Inhibition of ErbB2 by Herceptin reduces survivin expression via the ErbB2-beta-catenin/TCF4-survivin pathway in ErbB2-overexpressed breast cancer cells.
authors.affiliation: Laboratory of Cell and Molecular Biology, State Key Laboratory of Molecular Oncology, Beijing, China.
authors.forename: Hongxia
authors.initials: H
authors.lastname: Zhu
authors.forename: Guo
authors.initials: G
authors.lastname: Zhang
authors.forename: Yan
authors.initials: Y
authors.lastname: Wang
authors.forename: Ninghong
authors.initials: N
authors.lastname: Xu
authors.forename: Shun
authors.initials: S
authors.lastname: He
authors.forename: Wei
authors.initials: W
authors.lastname: Zhang
authors.forename: Meigui
authors.initials: M
authors.lastname: Chen
authors.forename: Mei
authors.initials: M
authors.lastname: Liu
authors.forename: Lanping
authors.initials: L
authors.lastname: Quan
authors.forename: Jingfeng
authors.initials: J
authors.lastname: Bai
authors.forename: Ningzhi
authors.initials: N
authors.lastname: Xu